Patient care is changing globally due to the increasing aging population and the rising prevalence of chronic diseases, which results in higher demand for personalized medicine and the latest technologies. Following this, the global medtech market is continuously transforming with the rapid adoption of technological advancements like AI and ML.
Amid this backdrop, fundamentally sound medtech stocks Becton, Dickinson and Company (BDX), Medtronic plc (MDT), and Abbott Laboratories (ABT) could be ideal portfolio additions as they revolutionize patient care.
